Records containing: Liver Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-12-08
Trop2-targeted immunoPET Imaging of Solid Tumors
CLINICAL_TRIALS study record update · 2025-12-03
Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
CLINICAL_TRIALS study record update · 2025-12-01
Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing
CLINICAL_TRIALS study record update · 2025-11-26
National Liver Cancer Screening Trial
CLINICAL_TRIALS study record update · 2025-11-21
A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab Versus Placebo for Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-11-19
Phase II Non-Randomized Trial of Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
CLINICAL_TRIALS study record update · 2025-11-18
The Theraprutic Effect of New Drugs for Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2025-11-18
Molecular and Immunological Signatures in Recurrent Hepatocellular Carcinoma (HCC)
CLINICAL_TRIALS study record update · 2025-11-12
Fibrolamellar Carcinoma Global Dynamic Registry
CLINICAL_TRIALS study record update · 2025-11-10
A Phase II Study of Maintenance Zanzalintinib and Durvalumab in Patients With Advanced Hepatocellular Cancer After Induction Tremelimumab Plus Durvalumab
CLINICAL_TRIALS study record update · 2025-10-30
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C
CLINICAL_TRIALS study record update · 2025-10-15
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
CLINICAL_TRIALS study record update · 2025-10-09
Malignant Liver Tumors Who Are Unsuitable for Surgical Resection, Irreversible Electroporation (IRE) Ablation Will be Performed for Tumors Located Adjacent to Blood Vessels.
CLINICAL_TRIALS study record update · 2025-10-07
Contrast-Enhanced Ultrasound Evaluation of Radioembolization Treatment Response
CLINICAL_TRIALS study record update · 2025-10-03
To Evaluate the Safety and Efficacy of Ultrasound-guided HIFU for the Symptom Relief of Inoperable Abdominal Tumors.
CLINICAL_TRIALS study record update · 2025-10-02
Integrating Longitudinal Biomarker Dynamics With Clinical Features for Prognostic Prediction in Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2025-09-23
A Pilot Study of 68Ga-PSMA-11 PET-directed Radioligand Therapy in Patients With Metastatic Hepatocellular Carcinoma (HCC)
CLINICAL_TRIALS study record update · 2025-09-22
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women (OvAR-Y): an In-Silico Feasibility Trial
CLINICAL_TRIALS study record update · 2025-09-22
Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
CLINICAL_TRIALS study record update · 2025-09-19
Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells as Immunotherapy for Patients With Pediatric Solid Tumors
CLINICAL_TRIALS study record update · 2025-09-15
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
CLINICAL_TRIALS study record update · 2025-09-10
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors Within the IMAGIO Project (A-IMAGIO)
CLINICAL_TRIALS study record update · 2025-09-08
An Open-Label, Dose Escalation, Multi-Center Phase I/II Research Trial to Assess the Safety of ET140203 T Cells and Determine the Recommended Phase II Dose (RP2D) in Adults With Advanced Hepatocellular Carcinoma (HCC) (ARYA-1)
CLINICAL_TRIALS study record update · 2025-09-03
Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? (Study LIVERaTION)
CLINICAL_TRIALS study record update · 2025-09-03
A Phase I Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SON-DP in Subjects With Advanced Solid Tumors